Saltar al contenido
Merck

Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export.

Developmental cell (2019-11-19)
Caitlin W Brown, John J Amante, Peter Chhoy, Ameer L Elaimy, Haibo Liu, Lihua Julie Zhu, Christina E Baer, Scott J Dixon, Arthur M Mercurio
RESUMEN

Ferroptosis, regulated cell death characterized by the iron-dependent accumulation of lethal lipid reactive oxygen species, contributes to tissue homeostasis and numerous pathologies, and it may be exploited for therapy. Cells differ in their sensitivity to ferroptosis, however, and a key challenge is to understand mechanisms that contribute to resistance. Using RNA-seq to identify genes that contribute to ferroptosis resistance, we discovered that pro-ferroptotic stimuli, including inhibition of the lipid hydroperoxidase GPX4 and detachment from the extracellular matrix, induce expression of prominin2, a pentaspanin protein implicated in regulation of lipid dynamics. Prominin2 facilitates ferroptosis resistance in mammary epithelial and breast carcinoma cells. Mechanistically, prominin2 promotes the formation of ferritin-containing multivesicular bodies (MVBs) and exosomes that transport iron out of the cell, inhibiting ferroptosis. These findings reveal that ferroptosis resistance can be driven by a prominin2-MVB-exosome-ferritin pathway and have broad implications for iron homeostasis, intracellular trafficking, and cancer.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Seroalbúmina bovina, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Deferoxamine mesylate salt, powder, ≥92.5% (TLC)
Sigma-Aldrich
Anti-α-tubulina monoclonal antibody produced in mouse, ascites fluid, clone B-5-1-2
Sigma-Aldrich
Hydrocortisone, ≥98% (HPLC)
Sigma-Aldrich
Ferrostatin-1, ≥95% (HPLC)
Sigma-Aldrich
GW4869, ≥90% (NMR)
Sigma-Aldrich
Insulina from bovine pancreas, ≥25 USP units/mg (HPLC), powder
Sigma-Aldrich
ML 210, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human TSG101
Sigma-Aldrich
MISSION® esiRNA, targeting human PROM2
Sigma-Aldrich
MISSION® esiRNA, targeting human FTH1
Sigma-Aldrich
MISSION® esiRNA, targeting human FTL